Operating Margin of RIGEL PHARMACEUTICALS INC from 31 Dec 2016 to 31 Dec 2025
- Taxonomy & unit
- ratio: %
- Description
- The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
- Summary
-
RIGEL PHARMACEUTICALS INC quarterly and annual Operating Margin in % history and change rate from 31 Dec 2016 to 31 Dec 2025.
- RIGEL PHARMACEUTICALS INC Operating Margin for the quarter ending 31 Dec 2025 was 43%, a 216% increase year-over-year.
- RIGEL PHARMACEUTICALS INC annual Operating Margin for 2025 was 43%, a 216% increase from 2024.
- RIGEL PHARMACEUTICALS INC annual Operating Margin for 2024 was 13%.
- RIGEL PHARMACEUTICALS INC annual Operating Margin for 2023 was -18%, a 62% increase from 2022.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)
RIGEL PHARMACEUTICALS INC Quarterly Operating Margin (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| Q4 2025 | 43% | +29% | +216% | 01 Oct 2025 | 31 Dec 2025 |
| Q3 2025 | 42% | +36% | +599% | 01 Jul 2025 | 30 Sep 2025 |
| Q2 2025 | 39% | +46% | 01 Apr 2025 | 30 Jun 2025 | |
| Q1 2025 | 22% | +34% | 01 Jan 2025 | 31 Mar 2025 | |
| Q4 2024 | 13% | +31% | 01 Oct 2024 | 31 Dec 2024 | |
| Q3 2024 | 6% | +21% | 01 Jul 2024 | 30 Sep 2024 | |
| Q2 2024 | -6.9% | +20% | +74% | 01 Apr 2024 | 30 Jun 2024 |
| Q1 2024 | -12% | +20% | +62% | 01 Jan 2024 | 31 Mar 2024 |
| Q4 2023 | -18% | +29% | +62% | 01 Oct 2023 | 31 Dec 2023 |
| Q3 2023 | -15% | +73% | +83% | 01 Jul 2023 | 30 Sep 2023 |
| Q2 2023 | -27% | +64% | +70% | 01 Apr 2023 | 30 Jun 2023 |
| Q1 2023 | -32% | +62% | +66% | 01 Jan 2023 | 31 Mar 2023 |
| Q4 2022 | -46% | -38% | -452% | 01 Oct 2022 | 31 Dec 2022 |
| Q3 2022 | -88% | -82% | -1215% | 01 Jul 2022 | 30 Sep 2022 |
| Q2 2022 | -91% | -88% | -3257% | 01 Apr 2022 | 30 Jun 2022 |
| Q1 2022 | -95% | -89% | -1439% | 01 Jan 2022 | 31 Mar 2022 |
| Q4 2021 | -8.4% | +18% | +69% | 01 Oct 2021 | 31 Dec 2021 |
| Q3 2021 | -6.7% | +19% | +74% | 01 Jul 2021 | 30 Sep 2021 |
| Q2 2021 | -2.7% | +21% | +89% | 01 Apr 2021 | 30 Jun 2021 |
| Q1 2021 | -6.2% | +23% | +79% | 01 Jan 2021 | 31 Mar 2021 |
| Q4 2020 | -27% | +90% | +77% | 01 Oct 2020 | 31 Dec 2020 |
| Q3 2020 | -26% | +34% | +57% | 01 Jul 2020 | 30 Sep 2020 |
| Q2 2020 | -24% | +70% | +75% | 01 Apr 2020 | 30 Jun 2020 |
| Q1 2020 | -29% | +87% | +75% | 01 Jan 2020 | 31 Mar 2020 |
| Q4 2019 | -117% | 01 Oct 2019 | 31 Dec 2019 | ||
| Q3 2019 | -60% | 01 Jul 2019 | 30 Sep 2019 | ||
| Q2 2019 | -94% | 01 Apr 2019 | 30 Jun 2019 | ||
| Q1 2019 | -116% | 01 Jan 2019 | 31 Mar 2019 |
RIGEL PHARMACEUTICALS INC Annual Operating Margin (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| 2025 | 43% | +29% | +216% | 01 Jan 2025 | 31 Dec 2025 |
| 2024 | 13% | +31% | 01 Jan 2024 | 31 Dec 2024 | |
| 2023 | -18% | +29% | +62% | 01 Jan 2023 | 31 Dec 2023 |
| 2022 | -46% | -38% | -452% | 01 Jan 2022 | 31 Dec 2022 |
| 2021 | -8.4% | +18% | +69% | 01 Jan 2021 | 31 Dec 2021 |
| 2020 | -27% | +90% | +77% | 01 Jan 2020 | 31 Dec 2020 |
| 2019 | -117% | +47% | +29% | 01 Jan 2019 | 31 Dec 2019 |
| 2018 | -163% | +1612% | +91% | 01 Jan 2018 | 31 Dec 2018 |
| 2017 | -1776% | -1433% | -419% | 01 Jan 2017 | 31 Dec 2017 |
| 2016 | -342% | 01 Jan 2016 | 31 Dec 2016 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.